Last reviewed · How we verify
PNL-THC:CBD soft gelatin capsule
PNL-THC:CBD soft gelatin capsule is a Small molecule drug developed by PhytoTech Therapeutics, Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | PNL-THC:CBD soft gelatin capsule |
|---|---|
| Sponsor | PhytoTech Therapeutics, Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PNL-THC:CBD soft gelatin capsule CI brief — competitive landscape report
- PNL-THC:CBD soft gelatin capsule updates RSS · CI watch RSS
- PhytoTech Therapeutics, Ltd. portfolio CI
Frequently asked questions about PNL-THC:CBD soft gelatin capsule
What is PNL-THC:CBD soft gelatin capsule?
PNL-THC:CBD soft gelatin capsule is a Small molecule drug developed by PhytoTech Therapeutics, Ltd..
Who makes PNL-THC:CBD soft gelatin capsule?
PNL-THC:CBD soft gelatin capsule is developed by PhytoTech Therapeutics, Ltd. (see full PhytoTech Therapeutics, Ltd. pipeline at /company/phytotech-therapeutics-ltd).
What development phase is PNL-THC:CBD soft gelatin capsule in?
PNL-THC:CBD soft gelatin capsule is in Phase 1.